Target Therapies for Systemic Mastocytosis: An Update

Target Therapies for Systemic Mastocytosis: An Update

Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MCs) in extra-cutaneous organs. It could be divided into indolent SM, smoldering SM, SM with an associated hematologic (non-MC lineage) neoplasm, aggressive SM, and mast cell leukemia. SM is generally associated w...

Full description

Bibliographic Details
Main Authors: Mariarita Sciumè, Claudio De Magistris, Nicole Galli, Eleonora Ferretti, Giulia Milesi, Pasquale De Roberto, Sonia Fabris, Federica Irene Grifoni
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pharmaceuticals
Subjects:
systemic mastocytosis
target therapy
midostaurin
imatinib
avapritinib
Online Access:https://www.mdpi.com/1424-8247/15/6/738

Internet

https://www.mdpi.com/1424-8247/15/6/738

Similar Items